Advancements in digital health technologies post-pandemic have propelled the shift towards at-home cancer care, with remote patient monitoring (RPM) emerging as a pivotal tool. Led by Glen Peterson and his team, a study explored the feasibility of RPM in delivering at-home oncology care to high-risk cancer patients, revealing promising outcomes. However, successful implementation requires careful consideration of patient engagement, resource allocation, and technology selection. With continued support from healthcare stakeholders, RPM has the potential to revolutionize cancer care delivery, enhancing patient outcomes and experiences while reducing healthcare costs.
The landscape of healthcare delivery has undergone a profound transformation post-pandemic, with a notable shift towards at-home care facilitated by digital health technologies. Amongst chronic conditions, cancer care stands to benefit significantly from this evolution. Glen Peterson and his team at the University of Colorado Medicine embarked on a study to explore the viability of leveraging remote patient monitoring (RPM) to deliver at-home oncology care to high-risk cancer patients. This paper examines the findings of their research and discusses critical considerations for the successful implementation of RPM-supported cancer care models.
Glen Peterson, DNP, ACNP, RN, an associate professor of hematology at the University of Colorado Medicine (CU Medicine), highlights the significance of this shift, particularly for high-risk cancer patients. “Providing better care that is centered around the patient, and doing this at a lower cost is one of the priorities and goals of at-home care,” Peterson emphasizes. He notes that the prevalence of virtual visits surged due to the heightened risks associated with COVID-19, especially for vulnerable populations like cancer patients.
In a recent study presented at the 2023 American Society of Hematology (ASH) Annual Meeting and Exposition, Peterson and his team, in collaboration with Reimagine Care, explored the feasibility of leveraging remote patient monitoring (RPM) to deliver at-home oncology care to high-risk cancer patients. The study, supported by CU Innovations at the University of Colorado Anschutz Medical Campus, focused on patients undergoing bone marrow transplant and CAR T-cell therapy, who are particularly susceptible to complications.
The findings revealed that RPM technologies, including biometric sensors for passive vital sign monitoring and a chatbot system for symptom reporting, facilitated early intervention and treatment. Participants wore these devices for up to 30 or 90 days post-treatment, enabling continuous monitoring and timely alerts for healthcare providers. The study demonstrated a high level of engagement from both patients and healthcare personnel, with the majority reporting positive experiences and improved understanding of care plans.
Despite the success of the at-home cancer care program, Peterson underscores several critical considerations for its implementation. He emphasizes the importance of integrating RPM into a comprehensive care model that includes adequate staffing and financial resources. Furthermore, patient engagement emerges as a key factor in the success of RPM-supported care models. Patients and caregivers need to recognize the benefits of RPM in enhancing safety, access to care, and reducing caregiver burden to remain actively engaged in the program.
Selecting the right technology and vendor partner is another crucial aspect highlighted by Peterson. RPM solutions should enable continuous monitoring and seamless communication with patients, while also integrating effectively with electronic health records (EHRs) to ensure seamless data flow. However, the broader adoption of RPM hinges on the support of healthcare payers, as Peterson emphasizes the need for greater attention to the financial benefits and cost savings associated with these approaches.
Looking ahead, Peterson envisions a future where remote patient monitoring is coupled with more at-home care interventions, aiming to keep patients out of hospitals and clinics unless necessary. The ultimate goal is to enhance early detection of complications and side effects while providing quicker access to care in the comfort of patients’ homes.
As healthcare continues to evolve, remote patient monitoring (RPM) emerges as a game-changer in the delivery of at-home cancer care. The study led by Glen Peterson and his team demonstrates the feasibility and potential benefits of RPM in improving patient outcomes and experiences. However, realizing the full potential of RPM requires addressing challenges such as patient engagement, resource allocation, and technology integration. With concerted efforts from healthcare stakeholders, RPM has the power to revolutionize cancer care delivery, bringing it closer to patients’ homes while ensuring timely interventions and cost-effective solutions.
